| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/08/2004 | US20040005664 Novel 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 molecules and uses therefor |
| 01/08/2004 | US20040005619 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |
| 01/08/2004 | US20040005596 Gene amplification in cancer |
| 01/08/2004 | US20040005593 Novel method for delivery and intracellular synthesis of siRNA molecules |
| 01/08/2004 | US20040005588 Using DNA vaccines to treat and prevent insulin depentent diabetes mellitus |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005578 Myocardial cell proliferation-associated genes |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005570 Oligonucleotides which control expression of geranylgeranyl diphosphate synthase for treating tumors, apoptosis aberrations and developmental disorders; gene expression inhibition; antisense therapy |
| 01/08/2004 | US20040005569 Antisense modulation of NF-kappa-B p50 subunit expression |
| 01/08/2004 | US20040005567 Antisense modulation of cyclin-dependent kinase 4 expression |
| 01/08/2004 | US20040005558 Proteins, polynucleotides ecoding them and methods of using the same |
| 01/08/2004 | US20040005557 Comprises polypeptide for diagnosing and treating inflammatory, nervous system, autoimmune and infectious disorders |
| 01/08/2004 | US20040005550 Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3 |
| 01/08/2004 | US20040005537 Method of identifying toxic agents using differential gene expression |
| 01/08/2004 | US20040005353 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is |
| 01/08/2004 | US20040005334 Redirection of cellular immunity by receptor chimeras |
| 01/08/2004 | US20040005324 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 01/08/2004 | US20040005313 Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/08/2004 | US20040005296 Gene therapy targeted to ischemic tissues. |
| 01/08/2004 | US20040005294 Insulin-like growth factor binding protein expression can be diagnostic of cancer development and progression. |
| 01/08/2004 | US20040005293 High capacity recombinant adenoviral vector for treatment of hemophilia A |
| 01/08/2004 | CA2491034A1 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490367A1 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | CA2490017A1 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2487712A1 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | CA2392863A1 A high capacity recombinant adenoviral vector for treatment of hemophilia a |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378017A1 Heterostructure component |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377673A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 01/07/2004 | EP1377672A2 Vector constructs |
| 01/07/2004 | EP1377671A2 Oncolytic adenoviral vectors |
| 01/07/2004 | EP1377668A2 Artificial chromosomes comprising ehv sequences |
| 01/07/2004 | EP1377660A2 Vaccine against the nile fever virus |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1465702A Purifying and use for human vascular endothelial growth factor and granzyme B fusion protein |
| 01/07/2004 | CN1465701A Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 01/06/2004 | US6673911 Human polyhomeotic 2 (hph2) acts as an oncogene |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673776 Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673612 Generation of micelle for the transfer of biopolymers to cells; form cationic reverse micelle using amphipathic molecules, insert bipolymer, adjust the charge of micelle , transfer to cells |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673605 Established cell line of microglia |
| 01/06/2004 | US6673604 Muscle cells and their use in cardiac repair |
| 01/06/2004 | US6673602 Herpes simplex virus amplicon vector targeting system and method of using same |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673354 Compositions and methods for treating papillomavirus-infected cells |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673352 Use of Mullerian inhibiting substance for treating excess androgen states |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673039 Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/02/2004 | EP1375672A1 Method of detecting nucleic acid relating to disease |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1374909A2 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373537A2 Viral vectors |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373501A2 Targeting molecules for adenoviral vectors |
| 01/02/2004 | EP1373500A2 Gene involved in v(d)j recombination and/or dna repair |
| 01/02/2004 | EP1373492A1 Alpha-galactosidase as food-grade genetic marker |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373474A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |